Edition:
United States

GW Pharmaceuticals PLC (GWPRF.PK)

GWPRF.PK on OTC Markets Group

8.65USD
20 Sep 2017
Change (% chg)

$0.10 (+1.17%)
Prev Close
$8.55
Open
$8.64
Day's High
$8.72
Day's Low
$8.55
Volume
3,974
Avg. Vol
2,507
52-wk High
$11.53
52-wk Low
$7.68

Chart for

About

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers... (more)
No analyst recommendations are available for .

Overall

Beta: 1.37
Market Cap(Mil.): £2,056.57
Shares Outstanding(Mil.): 25.33
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 80.38 16.25
EPS (TTM): -- -- --
ROI: -- 2.96 14.87
ROE: -- 4.74 13.89

Earnings vs. Estimates